Clinical Trial Update: Comparison and Strategy Optimization of Plasma EBV DNA and P85-Ab with VCA/EBNA1-IgA for Screening Nasopharyngeal Carcinoma in High-risk Areas [NA]

View source ↗

Summary

A recruiting clinical trial comparing plasma EBV DNA and P85-Ab with VCA/EBNA1-IgA to screen for nasopharyngeal carcinoma in high-risk areas.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Snippet

Sponsor: Ming-Yuan Chen | Conditions: Nasopharyngeal Carcinoma (NPC), Screening | NA | Status: RECRUITING